Markets:

Overview

News

Currencies

International

Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

144.95 +2.69 (+1.89%)

Streaming Delayed Price Updated: 10:30 AM EST, Dec 5, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

22 23 Next >

MASIMO CORPORATION SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Masimo Corporation (NASDAQ: MASI)

August 24, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Masimo Corporation (MASI) Investors

August 24, 2023

From Law Offices of Howard G. Smith

Via Business Wire

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Masimo Corporation (MASI) Investors

August 24, 2023

From Kirby McInerney LLP

Via Business Wire

What 7 Analyst Ratings Have To Say About Masimo ↗

August 09, 2023

Via Benzinga

Why Shares of Masimo Are Dropping Tuesday ↗

July 18, 2023

The company's preliminary second-quarter numbers have investors worried.

Via The Motley Fool

MASI INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Masimo Corporation Investors with Substantial Losses Have Opportunity to Lead the Masimo Class Action Lawsuit

August 23, 2023

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Masimo Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – MASI

August 23, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Masimo Corporation

August 23, 2023

From Robbins LLP

Via Business Wire

Masimo Announces Full Market Release of Stork™ Smart Home Baby Monitor

August 23, 2023

From Masimo

Via Business Wire

New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Elderly Patients Undergoing Gastrointestinal Surgery

August 21, 2023

From Masimo

Via Business Wire

Masimo Reports Second Quarter 2023 Financial Results

August 08, 2023

From Masimo Corporation

Via Business Wire

New Study Finds That Masimo SedLine® Patient State Index (PSi) Has the Potential to Improve Brain Monitoring for Patients Sedated with Dexmedetomidine

August 07, 2023

From Masimo

Via Business Wire

Masimo, Medical Device Maker Drops on Q2 Guidance, Opportunity?

July 25, 2023

Shares of Masimo are at their lowest level since January 2019 — but according to Wall Street, could have healthy gains ahead.

Via MarketBeat

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Masimo Corporation (MASI) on Behalf of Investors

July 20, 2023

From Law Offices of Howard G. Smith

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Masimo Corporation (MASI) on Behalf of Investors

July 19, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Masimo Corporation (MASI) on Behalf of Investors

July 19, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

Nasdaq Futures Rise As Focus Turns To Tesla, Netflix Q2 Prints: Analyst Says Earnings Need Some 'Heavy Lifting' For Sustained Rally ↗

July 19, 2023

Via Benzinga

Nasdaq Gains Over 100 Points; Lockheed Martin Profit Tops Expectations ↗

July 18, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 1.09% to 34,961.65 while the NASDAQ rose 0.91% to 14,374.77....

Via Benzinga

Delay In Large Orders, Lower Inpatient Census To Ail Masimo's Q2 Results, Analyst Lowers Estimates ↗

July 18, 2023

Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ: MASI), lowering the

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

July 18, 2023

During Tuesday's trading, 46 companies set new 52-week lows.

Via Benzinga

Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 18, 2023

Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring.

Via Benzinga

Dow Jumps Over 300 Points; Morgan Stanley Posts Upbeat Earnings ↗

July 18, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 300 points on Tuesday. The Dow traded up 1% to 34,932.08 while the NASDAQ rose 0.34% to 14,293.55. The S&P 500, also...

Via Benzinga

Masimo Plummets To Five-Year Low On Light Sales, 'Longer-Term' Challenges Persist ↗

July 18, 2023

The company works primarily in health care, but its non-health care efforts are floundering.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023 ↗

July 18, 2023

Via Benzinga

CMG Stock Alert: Chipotle Announces International Expansion Plan ↗

July 18, 2023

Chipotle Mexican Grill (CMG) stock is in the news Tuesday after the restaurant chain announced plans for an international expansion.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 18, 2023

Via Benzinga

Why Is CEL-SCI (CVM) Stock Down 23% Today? ↗

July 18, 2023

CEL-SCI (CVM) stock is dropping on Tuesday after the biotechnology company announced details of a public share offering.

Via InvestorPlace

Why Is Masimo (MASI) Stock Down 30% Today? ↗

July 18, 2023

Masimo (MASI) stock is taking a beating on Tuesday after the patient monitoring tech company released preliminary earnings for Q2 2023.

Via InvestorPlace

Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket ↗

July 18, 2023

Gainers Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's...

Via Benzinga

Masimo Analysts Cut Their Forecasts Following Preliminary Q2 Results ↗

July 18, 2023

Masimo Corporation (NASDAQ: MASI) reported weak preliminary revenue results for the second quarter.

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.